Anne McDonald Pritchett, PhD (@pritchettpolicy) profile picture

Founder, Pritchett Policy Associates Senior Associate, Center for Strategic & International Studies Innovation policies, biopharma supply chain, US leadership

Virginia
Joined February 2025
Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)Photo by Anne McDonald Pritchett, PhD (@pritchettpolicy)
To better understand the role of terminal disclaimers check out the facts in @RealClearHealth from @Council4IP Board Members Judge Paul Michel and Judge Kathleen O'Malley. Read: realclearhealth.com/articles…
4
If lawmakers are serious about lowering drug costs, they must stop attacking the patent system that creates new medicines and hold PBMs accountable. The biggest market distortions aren't created by innovators -- they're created by middlemen. @SenJudiciaryGOP @JudiciaryDems
17
The Bayh-Dole Act has long fueled tech transfer making the US a global leader in innovation across sectors. Joe Allen recently joined @insidehighered to talk about Bayh-Dole’s role & threats to this landmark legislation. Listen here: insidehighered.com/news/quic…
1
12
How to encourage continued U.S. medical innovation explained by @Council4IP's Coke Morgan Stewart at @uiclaw: c4ip.org/wp-content/uploads/…
1
18
There are remedies for challenging patents. Let’s not weaken patent rights for everyone & impede the pace of medical innovation. In a new @HudsonInstitute report, Professor @AdamMossoff rebuts misinformation behind efforts to weaken patent rights: hudson.org/intellectual-prop…
1
2
74
Learn more about the path from discovery to a medical advance for patients. Former NIH Senior Advisor Mark Rohrbaugh in @RealClearHealth, talks about how the Bayh-Dole Act enables the investment and partnerships needed to bring new treatments to patients: realclearhealth.com/articles…
9
The COINS Act would only serve to make it harder for American companies to acquire and develop promising medical innovations & allow Europe and others to jump ahead. Let’s not slow the pace of medical innovations key to addressing unmet U.S. patient needs. incubatecoalition.org/post/t…
67
90% + of U.S. prescriptions are filled with generics. Yet some in Congress wrongly assert patents are why patients pay more at the pharmacy counter (nope—it’s PBMs). The ETHIC Act won't fix drug prices, but would hurt R&D. My latest in @InsideSourcesDC: buff.ly/yFml2eS
1
20
Innovation never stops. Learn from @Council4IP how ongoing R&D has led to everything from safer cars to more effective medicines: c4ip.org/wp-content/uploads/…
1
16
Celebrating 50 years of the Copyright Act! recently celebrated its 50th anniversary. Learn more about how this law supports authors, musicians, filmmakers, and other creators in bringing their creativity to all of us: @CopyrightOffice: copyright.gov/events/copyrig…
19